登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
线性分子式:
CF3CH2OH
化学文摘社编号:
分子量:
100.04
UNSPSC Code:
12191601
NACRES:
NA.21
PubChem Substance ID:
EC Number:
200-913-6
Beilstein/REAXYS Number:
1733203
MDL number:
Assay:
≥99%
Bp:
77-80 °C (lit.)
Vapor pressure:
70 mmHg ( 25 °C)
vapor density
3.5 (vs air)
Quality Level
vapor pressure
70 mmHg ( 25 °C)
product line
ReagentPlus®
assay
≥99%
form
liquid
autoignition temp.
~896 °F
expl. lim.
42 %
dilution
(for general lab use)
refractive index
n20/D 1.3 (lit.)
pH
7
bp
77-80 °C (lit.)
mp
−44 °C (lit.)
density
1.373 g/mL at 25 °C (lit.)
SMILES string
OCC(F)(F)F
InChI
1S/C2H3F3O/c3-2(4,5)1-6/h6H,1H2
InChI key
RHQDFWAXVIIEBN-UHFFFAOYSA-N
General description
2,2,2-三氟乙醇(TFE)是一种有机化合物,化学式为 CF3CH2OH。TFE 是有机合成中常用的溶剂。它也可以用作蛋白质和多肽实验研究中的助溶剂。
Application
2,2,2-三氟乙醇可作为溶剂:
- 通过醛、丙二腈和间苯二酚或二美酮的无催化剂一锅缩合合成 2-氨基-3-氰基-4H-铬和四氢苯[b]吡喃衍生物。
- 在异相 ZIF-8(沸石咪唑酸框架)催化剂环境下,氨基与甲酸的 N-甲酰化。
- 通过蒽酰胺与烷基、芳基或杂芳基酮或醛的缩合制备 2-取代-2,3-二氢-4(1H)-喹唑啉酮衍生物。
- 用 H2O2(过氧化氢)对含硫化合物进行温和的选择性氧化。
Features and Benefits
由于电负性的三氟甲基的存在,2,2,2-三氟乙醇的酸性高于乙醇。
Legal Information
ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany
Still not finding the right product?
Explore all of our products under 2,2,2-三氟乙醇
signalword
Danger
Hazard Classifications
Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Eye Dam. 1 - Flam. Liq. 3 - Repr. 1B - STOT RE 2 Inhalation
target_organs
Blood
存储类别
3 - Flammable liquids
wgk
WGK 1
flash_point_f
86.0 °F - closed cup
flash_point_c
30 °C - closed cup
法规信息
危险化学品
此项目有
A facile parallel synthesis of trifluoroethyl-substituted alkynes.
Cui-Bo Liu et al.
Angewandte Chemie (International ed. in English), 51(25), 6227-6230 (2012-05-09)
Bei Feng et al.
Biomacromolecules, 13(12), 3917-3925 (2012-11-08)
In tissue engineering research, there has recently been considerable interest in using electrospun biomimetic nanofibers of hybrids, in particular, from natural and synthetic polymers for engineering different tissues. However, phase separation between a pair of much dissimilar polymers might give
Hannah A Strobel et al.
Tissue engineering. Part A, 24(19-20), 1492-1503 (2018-05-05)
Tissue-engineered human blood vessels may enable in vitro disease modeling and drug screening to accelerate advances in vascular medicine. Existing methods for tissue-engineered blood vessel (TEBV) fabrication create homogenous tubes not conducive to modeling the focal pathologies characteristic of certain
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| T63002-100G | 04061837365676 |
| T63002-25G | 04061837366000 |
| T63002-500G | 04061837366482 |



